Hester Biosciences reports 22% rise in Q3 net profit

19 Jan 2017 Evaluate

Hester Biosciences has reported results for third quarter ended December 31, 2016.

The company has reported 21.85% rise in its net profit at Rs 5.80 crore for the quarter under review as compared to Rs 4.76 crore for the same quarter in the previous year. Total income from operation of the company increased by 17.95% at Rs 28.52 crore for Q3FY17 as compared Rs 24.18 crore for the corresponding quarter previous year. 

Hester Biosciences is one of India’s leading animal healthcare companies and second largest poultry vaccine manufacturer. Located near Ahmedabad, Gujarat, Hester has a state-of-the-art manufacturing facility for products ranging from vaccines, health products to diagnostics. Hester’s services include seroprofiling for poultry flocks and mastitis control programs for cattle.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×